A
ALGS//CIK 0001799448
Aligos Therapeutics, Inc.
Market Data
$7.97+$1.01 (+14.43%)
ALGS · Last trade
Prev Close
$6.97
Range (30d)
$6.56 – $7.97
Recent Filings
- 10-K14.4 MBAligos Therapeutics, Inc.Mar 5, 8:08 AM ET·0001193125-26-092614
- 8-K138.0 KBAligos Therapeutics, Inc.Feb 4, 4:05 PM ET·0001193125-26-037558
- 10-Q9.3 MBAligos Therapeutics, Inc.Nov 6, 8:37 AM ET·0001193125-25-268203
- 8-K273.8 KBAligos Therapeutics, Inc.Nov 6, 8:30 AM ET·0001171843-25-007075
- 10-Q9.8 MBAligos Therapeutics, Inc.Aug 6, 4:13 PM ET·0000950170-25-104042
- 8-K283.3 KBAligos Therapeutics, Inc.Aug 6, 4:06 PM ET·0001171843-25-005116
- 8-K193.5 KBAligos Therapeutics, Inc.Jun 26, 4:09 PM ET·0001193125-25-148905
- 10-Q8.6 MBAligos Therapeutics, Inc.May 6, 8:14 AM ET·0000950170-25-063983
- 8-K278.9 KBAligos Therapeutics, Inc.May 6, 8:00 AM ET·0001171843-25-002781
- 10-K17.8 MBAligos Therapeutics, Inc.Mar 10, 8:07 AM ET·0000950170-25-035929
Insiders
10- Achneck HardeanChief Medical Officer
- Aneja NikhilPrincipal Accounting Officer
- Beigelman LeonidDirector, President
- BLATT LAWRENCEDirector, President and CEO
- Calhoun Lesley AnnSee Remarks
- Chavez MargaritaDirector
- Glaub Kathleen SeredaDirector
- Hirth PeterDirector
- Martell Bridget ADirector
- McClure Matthew W.Chief Medical Officer
Tickers
Addresses
business
ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA, 94080
mailing
ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA, 94080